Strong pound dampens Clinigen profits progress
Pharmaceutical products and services company Clinigen (CLIN:AIM) has warned that a stronger pound has created a headwind which will impact second half performance.The company reported interim organic revenue growth of 4% to £231.9...
23 February 2021